Dr. Nemechek’s application for a patent involving the use of transcutaneous auriculare vagus nerve stimulation (taVNS) for the treatment of autism, developmental disorders, and other medical conditions has been accepted for review by the U.S. Patent Office (US Patent Appl # 20230321437).
The basis for this patent is Dr. Nemechek’s over 20 years of experience in developing anti-inflammatory techniques that allow for improved functioning of the central nervous system.
